Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q, Valerio H, Cunningham EB, Shih STF, Silk D, Conway A, Treloar C, Murray C, Henderson C, Amin J, Read P, Dore GJ, Grebely J; ETHOS Engage Study Group. Cheng Q, et al. Among authors: shih stf. Value Health. 2024 Feb;27(2):216-225. doi: 10.1016/j.jval.2023.10.013. Epub 2023 Nov 10. Value Health. 2024. PMID: 37951538 Free article.
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
Cheng Q, Cunningham EB, Shih S, Amin J, Bruneau J, Artenie AA, Powis J, Litwin AH, Cooper C, Dalgard O, Hellard M, Bruggmann P, Marks P, Lacombe K, Stedman C, Read P, Hajarizadeh B, Dunlop AJ, Conway B, Feld JJ, Dore GJ, Grebely J; SIMPLIFY and D3FEAT Study Groups. Cheng Q, et al. Value Health. 2023 Jun;26(6):883-892. doi: 10.1016/j.jval.2022.12.016. Epub 2023 Jan 13. Value Health. 2023. PMID: 36646278
A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia.
Grebely J, Markus C, Causer LM, Silk D, Comben S, Lloyd AR, Martinez M, Cunningham EB, O'Flynn M, Dore GJ, Matthews S; National Australian Hepatitis C Point-of-Care Testing Program. Grebely J, et al. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):204-207. doi: 10.1016/S2468-1253(22)00355-7. Lancet Gastroenterol Hepatol. 2023. PMID: 36773609 No abstract available.
Health-related quality of life among people who inject drugs in Australia.
Cheng Q, Bajis S, Cunningham E, Shih STF, Schulz M, Marshall AD, Martin NK, Miners A, Hajarizadeh B, Wiseman V, Dore GJ, Grebely J. Cheng Q, et al. Among authors: shih stf. Qual Life Res. 2023 Nov;32(11):3195-3207. doi: 10.1007/s11136-023-03465-3. Epub 2023 Jun 23. Qual Life Res. 2023. PMID: 37351701 Free PMC article.
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis.
Shih STF, Cheng Q, Carson J, Valerio H, Sheehan Y, Gray RT, Cunningham EB, Kwon JA, Lloyd AR, Dore GJ, Wiseman V, Grebely J. Shih STF, et al. Lancet Reg Health West Pac. 2023 Apr 4;36:100750. doi: 10.1016/j.lanwpc.2023.100750. eCollection 2023 Jul. Lancet Reg Health West Pac. 2023. PMID: 37547040 Free PMC article.
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.
Krass I, Carter R, Mitchell B, Mohebbi M, Shih STF, Trinder P, Versace VL, Wilson F, Mc Namara KP. Krass I, et al. Among authors: shih stf. Diabetes Res Clin Pract. 2023 Mar;197:110566. doi: 10.1016/j.diabres.2023.110566. Epub 2023 Feb 3. Diabetes Res Clin Pract. 2023. PMID: 36738834 Clinical Trial.
31 results